Statins: is it really time to reassess benefits and risks?

N Engl J Med. 2012 May 10;366(19):1752-5. doi: 10.1056/NEJMp1203020. Epub 2012 Apr 25.
No abstract available

MeSH terms

  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus / chemically induced*
  • Female
  • Glycated Hemoglobin A
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hyperglycemia / chemically induced
  • Male
  • Risk Assessment

Substances

  • Glycated Hemoglobin A
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors